GE HealthCare revenue up in first quarter as a standalone company, but shares drop

Steady demand and supply chain improvements have helped it grow the business, even as inflation and foreign exchange rates pressure its income.

By Elise Reuter • Updated April 25, 2023

Know Labs hopes to advance non-invasive glucose sensor with proof-of-concept test

The company wants to use its Bio-RFID technology for glucose monitoring, and recently showed the device could detect and quantify specific molecules in water. 

By Nick Paul Taylor • April 25, 2023

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Philips says revenue rises 6%, sees €575M in recall-related legal costs

CEO Roy Jakobs expressed confidence in the company’s outlook for the year ahead and said setting aside the funds to resolve a U.S. class action lawsuit was “an important step.”

By Susan Kelly • April 24, 2023

Graphene ‘tattoo’ pacemaker senses and treats irregular heart beats in rats

While still in early stages of development, the tattoo material can mold to the heart, unlike the more rigid implanted pacemakers used today, reducing some of the problems with traditional and leadless technologies.

By Nick Paul Taylor • April 24, 2023

Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump

Analysts called the FDA approval a “positive” for Medtronic that “should somewhat aid in a turnaround of its U.S. diabetes franchise.”

By Nick Paul Taylor • April 24, 2023

Alphatec buys robotic spine navigation system for $55M

The spine surgery specialist expects the robotic platform to begin generating revenue in 2025.

By Susan Kelly • Updated April 21, 2023

Lawsuit accuses J&J subsidiary of selling faulty knee replacements

A patient who had DePuy’s Attune knee system implanted, and then replaced when it loosened, claims the company downplayed the risks of the device.

By Elise Reuter • Updated April 21, 2023

Friday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market

Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.

By Susan Kelly • April 21, 2023

Report names connected medical devices with the biggest cybersecurity risks

The findings come as medical device makers face upcoming FDA requirements for providing cybersecurity information as part of their pre-market submissions.

By Nick Paul Taylor • April 21, 2023

Nevro names Hologic exec as CEO

Kevin Thornal will take the reins from current CEO D. Keith Grossman, who will retire next week. 

By Elise Reuter • April 20, 2023

Abbott hit with FDA warning letter over unapproved changes to heart disease test

The FDA said that four changes made to the tests “could significantly affect the safety or effectiveness of the devices.”

By Nick Paul Taylor • Updated April 20, 2023

Fresenius flags fault with infusion system acquired last year in $240M deal

Fresenius noted a problem with the devices that can cause loss of power, potentially delaying or interrupting the supply of critical fluids and medications. 

By Nick Paul Taylor • April 20, 2023

J&J study data show dramatic benefit to multiple myeloma cell therapy

A study abstract inadvertently posted online showed J&J and Legend’s therapy, Carvykti, reduced the risk of disease progression or death by more than 70% over standard drugs.

By Ned Pagliarulo • April 19, 2023

Medtronic says it plans more layoffs, declines to specify locations

The company said it began notifying some employees on Tuesday, but would not confirm the number of positions or locations of the jobs that would be cut.

By Elise Reuter • April 19, 2023

Abbott boosts organic sales outlook as device demand accelerates

A rebound in surgical procedure volumes as hospital staffing improved at the start of the year partially offset a steep drop in COVID-19 testing sales.

By Susan Kelly • April 19, 2023

AFib study shows no effect on outcomes from 1-year delay of catheter ablation

Early treatment could be a boon for medtech companies such as Boston Scientific and Medtronic but is potentially challenging for healthcare systems. The new study suggests waits of up to a year will not harm patients.

By Nick Paul Taylor • April 19, 2023

Intuitive posted 26% jump in robotic procedures in Q1 as hospitals chipped away at backlog

The company experienced “some backlog effect from patients generally returning to more normalized healthcare routines, given the effect of the pandemic over several years.”

By Nick Paul Taylor • April 19, 2023

J&J raises forecast as medtech procedures recover

The company’s medical device business grew by more than 7% in the first quarter.

By Elise Reuter • April 18, 2023

Post-approval modification of high-risk devices linked to 30% jump in recall risk: study

The authors suggest improved post-marketing surveillance systems may be needed to mitigate risks to patient safety.

By Nick Paul Taylor • April 18, 2023

What medtech startups need to know about remote monitoring

Four medtech executives talked about the future of hospital at home, and the difference between consumer devices and medical devices, in an event hosted by the Colorado Bioscience Association.

By Elise Reuter • April 17, 2023

LivaNova CEO quits as firm announces higher-than-expected preliminary earnings

Analysts from Needham and Stifel had opposite takes on how McDonald’s departure will affect the company, which has struggled in recent years to bring new products to market. 

By Peter Green • April 17, 2023

Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage

With a standalone reader, Abbott said it is working to make the FreeStyle Libre 3 system available to people covered by Medicare. 

By Elise Reuter • April 17, 2023

Overcome the top 5 device management challenges of remote patient care with ease

As more organizations adopt RPM, they’re facing increasingly complex challenges managing, updating and securing their devices.

April 17, 2023

Proxy adviser backs diabetes device developer Sernova in fight against activist investors

Institutional Shareholders Services said the activist investors “failed to present a detailed explanation” of their case and recommended that shareholders vote for Sernova’s director nominees. 

By Nick Paul Taylor • April 17, 2023

Friday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff

From supporting AI-driven medical interventions to freeing up providers from administrative tasks, remote patient monitoring is raising the bar for care, says Medtronic’s CMO for patient monitoring.

By Susan Kelly • April 15, 2023